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Abstract
Background: On trigeminal ganglion neurons, pain-sensing P2X3 receptors are constitutively inhibited by brain natriuretic
peptide via its natriuretic peptide receptor-A. This inhibition is associated with increased P2X3 serine phosphorylation and
receptor redistribution to non-lipid raft membrane compartments. The natriuretic peptide receptor-A antagonist anantin
reverses these effects. We studied whether P2X3 inhibition is dysfunctional in a genetic familial hemiplegic migraine type-1
model produced by introduction of the human pathogenic R192Q missense mutation into the mouse CACNA1A gene (knock-
in phenotype). This model faithfully replicates several properties of familial hemiplegic migraine type-1, with gain-of-function
of CaV2.1 Ca
2þ channels, raised levels of the algogenic peptide calcitonin gene-related peptide, and enhanced activity of P2X3
receptors in trigeminal ganglia.
Results: In knock-in neurons, anantin did not affect P2X3 receptor activity, membrane distribution, or serine phosphoryl-
ation level, implying ineffective inhibition by the constitutive brain natriuretic peptide/natriuretic peptide receptor-A pathway.
However, expression and functional properties of this pathway remained intact together with its ability to downregulate
TRPV1 channels. Reversing the familial hemiplegic migraine type-1 phenotype with the CaV2.1-specific antagonist, o-agatoxin
IVA restored P2X3 activity to wild-type level and enabled the potentiating effects of anantin again. After blocking calcitonin
gene-related peptide receptors, P2X3 receptors exhibited wild-type properties and were again potentiated by anantin.
Conclusions: P2X3 receptors on mouse trigeminal ganglion neurons are subjected to contrasting modulation by inhibitory
brain natriuretic peptide and facilitatory calcitonin gene-related peptide that both operate via complex intracellular signaling.
In the familial hemiplegic migraine type-1 migraine model, the action of calcitonin gene-related peptide appears to prevail
over brain natriuretic peptide, thus suggesting that peripheral inhibition of P2X3 receptors becomes insufficient and con-
tributes to trigeminal pain sensitization.
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Background
Migraine is a common, disabling, and undertreated epi-
sodic brain disorder with incompletely understood
pathophysiology.1 Transgenic mouse models with
human monogenic migraine gene mutations are useful
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to identify and unravel the pathophysiological mechan-
isms potentially involved in migraine.2,3 Familial hemi-
plegic migraine type-1 (FHM1) is a rare subtype of
migraine4 caused by missense mutations in the
CACNA1A gene.5,6 This gene encodes the pore-forming
a1A subunit of neuronal voltage-gated calcium channel
type 2.1 (CaV2.1, P/Q-type) that triggers neurotransmit-
ter release.7,8 Transgenic knock-in (KI) mice with the
FHM1 R192Q mutation (FHM1 R192Q KI) in the
orthologous mouse CACNA1A gene show gain-of-func-
tion of CaV2.1 channels,
8–11 increased neurotransmis-
sion, cortical (glutamatergic) hyperexcitability that
might explain the increased susceptibility to cortical
spreading depression,8,9,12 and signs of migraine-like
pain behavior.13,14 Previous studies show that the
R192Q mutation also aﬀects the trigeminovascular
system that plays an integral role in migraine pain trans-
duction.2 In fact, the gain-of-function of CaV2.1 chan-
nels in trigeminal ganglion (TG) of KI mice leads to
increased calcitonin gene-related peptide (CGRP)
release15,16 and neuronal hyperexcitability.17
Furthermore, in trigeminal sensory neurons, the
R192Q mutation causes sensitization of ATP-gated
P2X3 receptors,18 which are considered to play a major
role in transducing peripheral nociception, including
migraine pain.19,20 In KI trigeminal neurons, the consti-
tutively higher amplitude of P2X3 currents is supported
by larger ambient CGRP levels, and it is associated with
decreased serine P2X3 phosphorylation and preferential
receptor localization to lipid raft membrane
compartments.21,22
In our search for endogenous mechanisms controlling
the function of P2X3 receptors, we have recently
observed that in the TG of wild-type (WT) mice, these
receptors are constitutively downregulated by endogen-
ous brain natriuretic peptide (BNP) via activation of its
receptor natriuretic peptide receptor-A (NPR-A).23,24
This phenomenon is readily observed by suppressing
BNP synthesis or inhibiting its receptors implying that
even rather small concentrations of this peptide are suf-
ﬁcient for NPR-A receptor-mediated inhibition of P2X3
receptors.24 Interestingly, sustained inactivation of the
BNP/NPR-A pathway in WT TG neurons enhances
membrane currents mediated by P2X3 receptors,
changes their membrane distribution and decreases
their serine phosphorylation, making the WT phenotype
of TG neurons close to the KI one.24 One attractive
hypothesis is that a deﬁcit in the BNP/NPR-A system
might account for the sensitization of P2X3 receptors
in KI TG. The implication of this hypothesis is that
for at least a genetic type of migraine, pain might origin-
ate from lack of intrinsic inhibition of P2X3 receptors,
thus paving the way for potentiation by ambient CGRP.
The present study examined this hypothesis by inves-
tigating the expression and function of the BNP/NPR-A
system in R192Q KI TG, as well as its ability to regulate
P2X3 receptor membrane distribution and serine phos-
phorylation. To this end, we used the selective NPR-A
blocker anantin to suppress NPR-A signaling23,24 and to
test the consequences on P2X3 receptor function. For the
purpose of comparison, we checked if BNP could aﬀect
TRPV1 channels that are a less sensitive target for this
peptide modulation.23 Thereafter, we employed the
CaV2.1 antagonist o-agatoxin IVA or the CGRP recep-
tor antagonist CGRP 8-37 to reverse the upregulated
P2X3 receptor activity of KI neurons18,22,25 and to ﬁnd
out the role (if any) of the NPR-A system.
Methods
Animals and TG primary culture preparations
FHM1 R192Q KI and WT littermates were used
for the experiments.9 All animal procedures were con-
ducted in accordance with the guidelines of the Italian
Animal Welfare Act. All treatment protocols were
approved by the Scuola Internazionale Superiore di
Studi Avanzati ethics committee and are in accordance
with the European Union guidelines and in accordance
with the 3R principles (using cultures and reducing the
number of mice). Genotyping was performed by PCR, as
previously reported.9 TG primary cultures were obtained
from animals at the age of P12–14 as described previ-
ously following general anesthesia with slowly raising
levels of CO2 and employed after 24 h from
plating.26 Ganglion tissue samples and cultures were col-
lected and processed in parallel for WT and R192Q KI
mice.
Chemicals and treatments
All reagents were purchased from Sigma–Aldrich
(Milan, Italy) except anantin, which was purchased
from US Biologicals (Salem, MA, USA); o-agatoxin
IVA, which was purchased from Tocris Bioscience
(Bristol, UK); and recombinant mouse BNP, which
was purchased from Phoenix Pharmaceuticals
(Burlingame, CA, USA). The speciﬁc NPR-A receptor
antagonist anantin, the CGRP receptor antagonist
CGRP 8-37, o-agatoxin IVA, and BNP peptide were
dissolved in sterile water and freshly diluted from the
stock to the desired concentrations before the experi-
ment. Anantin was applied for 30min up to 24 h at the
concentration of 500 nM to fully block NPR-A recep-
tors.27 CGRP 8-37 was applied overnight at 1M con-
centration to eﬀectively block CGRP receptors.28–30
BNP was applied at the dose of 100 ng/mL or 500 ng/
mL, as previously reported for sensory ganglia.23,31 We
used o-agatoxin IVA (200 nM) to selectively inhibit P/Q-
type (CaV2.1) Ca
2þ channels.32
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Membrane fractionation and Western blot
Total membrane protein extraction and fractionation into
lipid raft and non-raft membrane fractions were performed
as reported by Gnanasekaran et al.22 Immunoprecipitation
of P2X3 receptors was described earlier.33 Equal amounts of
proteins were separated in 10% sodium dodecyl sulfate-
polyacrilamide gel and transferred to nitrocellulose mem-
brane. Immunoblotting was done using the following
primary antibodies validated in former studies21,23,24: anti-
NPR-A (1:1000; Abcam, Cambridge, UK), anti-P2X3
(1:1000; Santa Cruz Biotechnology, Heidelberg,
Germany), anti-b-actin (1:5000; A5441, Sigma), anti-b-
tubulin III (1:2000; T5076, Sigma), anti-ﬂotillin 1 (1:250;
BD Biosciences, Milan, Italy), anti-phospho-Serine (1:500;
Millipore, Milan, Italy). Signals were revealed after incuba-
tion with secondary antibodies conjugated with horseradish
peroxidase by using the ECL detection system (Amersham
Biosciences, Piscataway, NJ, USA) and recorded by the
Alliance 4.7 (UVITEC, Cambridge, UK) digital imaging.
Immunocytochemistry
Immunocytochemistry was performed as previously
described23 on primary TG cultures prepared from
P12-P14 R192Q KI and WT mice. Primary antibodies
anti-NPR-A (1:1000, Abcam), anti-BNP (1:100, Phoenix
Pharmaceuticals), and b-tubulin III (1:2000, Sigma) were
used. The speciﬁcity of the antibodies used in this study
has been previously validated.23,31 Secondary antibodies
conjugated with Alexa Fluor-488 or Alexa Fluor-594
were purchased from Invitrogen (1:500; Milan, Italy).
Nuclei were counterstained with DAPI (Sigma). Cells
were mounted with Vectashield (Vector laboratories)
and analyzed at confocal microscope (Leica TCS SP2,
Wetzlar, Germany).
Enzyme-linked immunosorbent assay
Basal and stimulated intracellular cGMP concentrations
were evaluated in primary TG cultures after 24 h in vitro.
A commercial enzyme-linked immunosorbent assay
(ELISA) kit for cGMP (MBL International
Corporation, Woburn, MA, USA) was used, following
the manufacturer’s instructions as previously
described.23 Protein concentrations in cell lysates were
determined by the bicinchoninic acid method (Sigma).
The cGMP concentrations in pmol/mg of protein were
extrapolated from a best-ﬁt line calculated from serial
dilutions of a cGMP sample standard.
To determine BNP concentration in medium samples,
a commercial ELISA kit for mouse BNP was used
(Abnova, Hidelberg, Germany) following the instructions
of the manufacturer, as previously reported.23 After 24h
from plating cells, culture medium was collected. All sam-
ples were centrifuged at 1200 r/min for 5min, and the
supernatants immediately processed for BNP measure-
ment. Protein concentrations in cell lysates were deter-
mined by the bicinchoninic acid method (Sigma). All
samples were run in triplicate and values averaged.
Electrophysiology
Electrophysiological experiments were performed
according to the previously reported protocols.26,28
After 24 h incubation, trigeminal cultures were continu-
ously superfused during the experiment (3mL/min) with
physiological solution containing (in mM): 152 NaCl, 5
KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH
adjusted to 7.4 with NaOH). Neurons were patch-
clamped in the whole-cell conﬁguration using patch pip-
ettes with 3–4M resistance and ﬁlled with a solution
containing (in mM): 140 KCl, 0.5 CaCl2, 2 MgCl2, 2
Mg2ATP3, 2 GTP, 10 HEPES, and 10 EGTA (pH
adjusted to 7.2 with KOH). Recordings were obtained
from small and medium size trigeminal neurons,28 with
holding potential equal to 65mV after correction for
liquid junction potential. A total of 1 kHz ﬁltering was
used during recording; currents were acquired by means
of a DigiData 1200 interface and pClamp8.2 software
(Molecular Devices, Sunnyvale, CA, USA). To activate
P2X3 receptors, the stable synthetic agonist a,b-methy-
lene-adenosine-5’-triphosphate (a,b-meATP; Sigma)34
was applied for 2 s at the concentration of 10 mM23,34,35
to produce large current responses that we showed to be
strongly enhanced by anantin.23 Our previous study has
demonstrated that anantin application caused a leftward
shift in the a,b-meATP concentration response plot with-
out signiﬁcant change in the maximal response.23
a,b-meATP was administered using a fast superfusion
system (Rapid Solution Changer RSC-200; BioLogic
Science Instruments, Claix, France). Being a non-
hydrolysable analog of the natural P2X3 ligand adeno-
sine triphosphate (ATP), a,b-meATP is chemically very
stable and, in addition, possesses almost identical eﬃcacy
and potency compared to ATP itself.34,36
Capsaicin (1 mM, 3 s) was used to activate TRPV 1
receptors.18,28 For statistical analysis, data from at
least four individual experiments were collected, with
number of cells equal or greater than 25. Capsaicin-
and a,b-meATP-induced responses were measured as
peak current amplitudes, and current density values
(pA/pF) were then calculated to normalize current size
to the cell capacity and to eliminate diﬀerences origi-
nated from cell size variation.
Statistical analysis
Data are expressed as mean standard deviation (for
molecular biology experiments) or mean standard
error of the mean (for patch clamp experiments), where
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n indicates the number of independent experiments or
the number of investigated cells, as indicated in ﬁgure
legends. Statistical analysis was performed using non-
parametric Mann–Whitney rank sum test, or the
Student’s t test, after the software directed choice of
non-parametric or parametric data, respectively
(Matlab; Sigma Plot and Sigma Stat Software,
Chicago, IL, USA), or Kruskal–Wallis test for multiple
comparison. A p value of <0.05 was accepted as indica-
tive of a statistically signiﬁcant diﬀerence.
Results
Untethered P2X3 receptor activity from
BNP/NPR-A inhibition in KI neurons
In line with our previous reports on WT cells,23,24 sus-
tained (3–24 h) block of NPR-A receptors with anantin
(500 nM)25,37 demonstrated signiﬁcant enhancement of
P2X3 receptor currents evoked by their selective agonist
a,b-meATP (10M) (Figure 1(a)). This facilitation indi-
cates that anantin had reversed the P2X3 downregula-
tion by endogenous BNP.23,24 The eﬀect by anantin on
WT cells took P2X3 currents up to the value usually
observed in KI neurons (Figure 1(a)18). When applied
to KI neurons, anantin failed to further potentiate
P2X3 receptor currents after 3 or 24 h treatment
(Figure 1(a)), suggesting loss of modulation by the
endogenous BNP/NPR-A pathway.
In TG neurons, the BNP/NPR-A pathway increases
P2X3 serine phosphorylation (pSer) level and favors
P2X3 receptor distribution to non-lipid raft membrane
compartments.24 These two processes are critical regula-
tors of P2X3 receptor function.21,22 Figure 1(b) com-
pares pSer levels of immunopuriﬁed membrane P2X3
receptors from WT or KI cultures in control or ana-
ntin-treated condition. In the absence of anantin, P2X3
pSer was low in KI cells compared to that in WT cells
and was not changed by anantin application
(Figure 1(b)). As expected,24 treatment with anantin
resulted in a decreased pSer in WT samples (Figure 1(b)).
Figure 1(c) shows P2X3 receptor distribution between
lipid raft (ﬂotillin-labeled; see methods) and non-raft
membrane compartments in control or anantin-treated
cultures. Under control conditions, more P2X3 receptors
were distributed to the lipid raft compartment in KI TG
neurons compared with WT, as previously reported by
Gnanasekaran et al.22 It is noteworthy that, after ana-
ntin application to KI cultures, the predominant P2X3
receptor distribution to lipid rafts remained intact
(Figure 1(c)) unlike the previously reported redistribu-
tion to the lipid raft domain in WT samples.24 The
data in Figure 1 globally suggested that the upregulated
function of P2X3 receptors in KI neurons was not con-
stitutively inhibited by the NPR-A system. We,
therefore, searched for any deﬁcit in the expression of
BNP and NPR-A receptors in KI cells.
BNP and NPR-A expression and function in KI cells
In primary TG cultures from WT mice, NPR-A receptor
immunoreactivity was readily detected in 91.7 1.3% of
neurons (Figure 2(a), (b)) as shown by its colocalization
with b-tubulin III in accordance with previous data.23 In
primary TG cultures from KI mice, the percentage of b-
tubulin III-positive cells expressing NPR-A was even
higher (98.7 1.3%; p< 0.05) than in WT, indicating
that almost all KI trigeminal neurons expressed this recep-
tor (Figure 2(b)). Western blot analysis did not reveal
such diﬀerence at the NPR-A protein level between the
two genotypes, either in TG primary cultures from young
(P12) mice (Figure 2(c), left) or in TG tissue in situ from
adult (P30) animals (Figure 2(c), right).
Next, we investigated whether the NPR-A receptor
system was functional in KI TG. To this end, since acti-
vation of NPR-A by BNP has been shown to increase
intracellular cGMP production,38 we investigated if
application of BNP to WT and KI cultures could
increase intracellular cGMP to comparable levels.
Figure 2(d) shows that basal cGMP levels were similar
in WT and KI samples. Application of 500 ng/mL BNP
(vs. vehicle control) caused a similar rise in cGMP in WT
and KI samples in a time-related fashion. These eﬀects
were prevented by 500 nM anantin. It is noteworthy that
in WT and KI TG cultures, anantin per se signiﬁcantly
decreased the basal level of cGMP (Figure 1(d)), suggest-
ing constitutive activity of NPR-A receptors.
Consistent with previous ﬁndings that proposed a
mainly paracrine BNP action,23 immunocytochemistry
revealed scant presence of BNP-positive cells, in which
peptide staining appeared as cytoplasmic granules
(Figure 1(e)). In untreated TG cultures from WT ani-
mals, 2% 0.2 DAPI-stained cells were identiﬁed as
BNP-positive, while in KI ganglion culture, a slight
increase in immunopositive cells was observed (3.7
% 0.7; p< 0.05) (Figure 1(f)). We measured, with
ELISA assay, the concentration of BNP peptide in the
culture medium from WT or KI TG, which was found to
be 3.8 1.6 ng/mL and 4.1 1.8 ng/mL, respectively,
with no signiﬁcant diﬀerence between WT and KI.
KI cultures, thus, possessed an intact (or even slightly
enhanced) BNP/NPR-A system, indicating that in these
cells, the downstream pathway linking NPR-A to P2X3
was perhaps severed. To check if BNP could retain its
modulation of other pain-sensing receptors, we explored
if inhibition of TRPV1 receptors by exogenous BNP23
persisted in KI neurons. Thus, pre-incubating KI cul-
tures for 24 h with 100 ng/mL BNP signiﬁcantly
depressed currents evoked by the TRPV1 agonist capsa-
icin (Figure 3(a)), while it did not alter responses
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mediated by P2X3 receptors (Figure 3(b)). The inhibi-
tory eﬀect on TRPV1 receptors seen after BNP applica-
tion was fully prevented by concomitant administration
of 500 nM anantin (Figure 3(a)).
Overall, these data indicated rather small diﬀerences
in the BNP/NPR-A system between the two genotypes,
suggesting that loss of constitutive inhibition of
P2X3 receptors could not be attributed to deﬁcient
Figure 1. Anantin effects onWTor KI trigeminal neurons. (a) Representative traces obtainedwith a,b-meATP (10 mM, 2 s) application show
P2X3 current amplitudes in control and after 3 h anantin treatment (500 nM) in WTand KI trigeminal neurons. Histograms show average
P2X3 current density values fromWTor KI neurons in control or after 3 h or 24 h pretreatment with anantin (n¼ 25, 25, and 26 forWT; 42,
40, 34 for KI cells, respectively; *p< 0.05, Mann–Whitney rank sum test). Note that P2X3 currents in KI control are already potentiated
compared to WTand cannot be further enhanced by anantin application. (b) Western immunoblotting shows the amount of P2X3 pSer and
total amount of P2X3 receptors in control and after 24 h anantin (500 nM) application forWTand KI trigeminal cultures. b-tubulin was used as
loading control. Histograms on the right show statistically lower P2X3 pSer (relative optical density value) in WT cultures after anantin
application. In KI samples, pSer level is already low and is not altered by anantin (n¼ 4; *p< 0.05, Mann–Whitney rank sum test). (c) Top panel
is a representative example of Western immunoblotting showing the amount of P2X3 receptors in raft (R) and non-raft (NR) membrane
fractions in control or after treatment with anantin (500 nM, 24 h). Flotillin bands indicate lipid raft membrane fractions. Lower panel shows
total amount of P2X3 receptors for each experimental condition; b-tubulin was used as loading control. Histograms on the right quantify
mean P2X3 relative optical density values in lipid raft and non-raft membrane fractions (n¼ 4; *p< 0.05, Kruskal–Wallis test).
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Figure 2. BNP and NPR-A in WT and KI TGs. (a) Representative immunocytochemical examples of endogenous NPR-A expression in
WT (left panel) and KI (right panel) mouse TG cultures. Nuclei are visualized with DAPI (blue); scale bar¼ 50 mm. Note extensive
costaining of NPR-A (red) and b-tubulin (green). (b) The histograms quantify percentage of NPR-A positive cells in WT and KI cultures
(n¼ 4; *p< 0.05, Kruskal–Wallis test). (c) Western blot showing protein expression of NPR-A in TG from P30 mice (right) and TG
cultures from P12 mice (left). b-Actin was used as a loading control. Histograms (bottom) quantify NPR-A relative optical density values for
each examined group. (d) ELISA-based quantification of intracellular cGMP in TG cultures from WT and KI mice. Cultures were treated
with BNP (500 ng/ml for 5, 30, or 60min) and/or anantin (500 nM, 30min) or vehicle (indicated as 0). Note similar dynamics of cGMP
increase after BNP application and similar decrease after treatment with anantin alone (500 nM) throughout. Data were normalized to the
total protein content in each sample and are presented as mean value standard deviation (n¼ 3 in which samples were run in duplicate;
*p< 0.05, Kruskal–Wallis test). (e) Immunocytochemical analysis of BNP (red) in WTand KI mouse TG culture. Nuclei are visualized with
DAPI (blue). Scale bar, 15mm. (f) Histograms show percent value of BNP-positive cells in WT and KI populations (DAPI-labeled cells).
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agonist or receptor signal of the BNP/NPR-A system
in KI TG.
Reversing the gain-of-function phenotype of KI cells
restores NPR-A dependent inhibition
of P2X3 receptor activity
The gain-of-function of CaV2.1 (P/Q-type) Ca
2þ chan-
nels in KI TG neurons is selectively reversed by o-aga-
toxin IVA (200 nM) that also restores P2X3 currents to
WT level.18 Figure 4(a) indicates that overnight pre-
treatment with o-agatoxin IVA signiﬁcantly decreased
P2X3 currents in KI neurons18,22 and that anantin
could then regain its facilitatory action on P2X3 recep-
tors. In addition, o-agatoxin IVA increased P2X3 pSer
(Figure 4(b)) and shifted P2X3 receptors preferentially to
the non-raft membrane compartments (Figure 4(c)).
When anantin was coapplied with o-agatoxin IVA,
pSer P2X3 levels were signiﬁcantly reduced
(Figure 4(b)). Nonetheless, after o-agatoxin IVA had
decreased the amount of P2X3 receptors in the lipid
raft compartment of KI samples, anantin could not
change this eﬀect (Figure 4(c)).
CGRP receptor antagonism facilitates
the action of anantin in KI neurons
CGRP is a powerful positive regulator of P2X3 func-
tion.16,39–41 In TG neurons, CGRP stimulates P2X3
receptor neosynthesis and traﬃcking to the membrane.42
The basal potentiation of P2X3 receptor activity of KI
neurons is largely due to higher release of endogenous
CGRP from neuronal and non-neuronal sources.28 We
investigated whether, in KI TG cultures, BNP-mediated
inhibition of P2X3 receptors was swamped by the enhan-
cing action of ambient CGRP. Consistent with previous
data,28 treatment with the selective CGRP receptor
antagonist peptide CGRP 8-37 (1 mM, overnight)
decreased the mean current density of P2X3 responses
in KI cells (Figure 5(a)). Application of anantin during
the last 3 h of CGRP 8-37 administration restored a,b-
meATP-elicited currents to a level close to that in the
control situation (Figure 5(a), right). Nonetheless, nei-
ther CGRP 8-37 alone nor its combination with anantin
changed pSer P2X3 levels of KI TG (Figure 5(b)). The
distribution of P2X3 receptors between raft and non-raft
membrane compartments of KI TG is illustrated in
Figure 5(c). Antagonizing CGRP receptor function
reduced P2X3 protein levels both in the lipid raft and
in the non-raft compartments. Coapplication of CGRP
8-37 with anantin increased the fraction of P2X3 recep-
tors in the raft compartment with a corresponding fall in
the non-raft compartment (Figure 5(c)).
Discussion
The primary ﬁnding of the study is the demonstration
that the BNP/NPR-A system, which downregulates
P2X3 receptors in WT trigeminal neurons, lost this abil-
ity in a transgenic mouse model of FHM1. This novel
observation suggests that sensitization of P2X3 receptors
may occur not only because of enhancing action of
migraine mediators like CGRP19,43 but also because an
endogenous inhibitor becomes poorly functional. The
observation that overwhelming majority of TG neurons
expresses NPR-A receptors is compatible with their pro-
posed role in controlling activity of sensory neurons.
Intact BNP/NPR-A system in KI TG
Increased P2X3 activity of KI TG neurons is associated
with preferential P2X3 receptor redistribution to lipid
Figure 3. Effect of exogenous BNP on TRPV1- and P2X3-
mediated responses in KI TG neurons. (a) Representative traces of
capsaicin (1mM, 3 s)-induced TRPV1 currents of KI trigeminal
neurons in control and after application of BNP (100 ng/mL, 24 h)
alone or in combination with anantin (500 ng/mL, 24 h).
Histograms on the right summarize mean current density values of
TRPV1 currents. Note that BNP suppresses TRPV1 responses and
that the effect is fully blocked by anantin (n¼ 39, 42, 47, *p< 0.05,
Mann–Whitney rank sum test). (b) Representative traces of a,b-
meATP (10 mM, 2 s)-evoked P2X3 responses of KI trigeminal
neurons in control and after application of BNP (100 ng/mL, 24 h)
or BNP together with anantin (500 ng/mL, 24 h). Histograms on
the right summarize mean current density values of P2X3 currents.
Note that exogenous BNP does not affect P2X3 currents (n¼ 38,
51, 33, *p5 0.05, Mann–Whitney rank sum test).
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raft membrane compartments22 and reduced receptor
pSer level.21 Notably, in WT cells, these properties of
P2X3 receptors are controlled by the BNP/NPR-A
system in the opposite direction via BNP itself rather
than related peptides.23,24 The present study demon-
strated that when NPR-A receptors of KI neurons
were blocked by anantin, no increase in P2X3 function
ensued, indicating ineﬀective constitutive inhibition. The
KI phenotype was, therefore, not inﬂuenced by the BNP/
NPR-A system despite normal expression level of BNP
and NPR-A, and cGMP synthesis.
On the other hand, while TRPV1 receptor function in
KI trigeminal cultures is unchanged,18,28 the BNP/NPR-A
system could still negatively modulate TRPV1-mediated
Figure 4. o-agatoxin IVA restores anantin effects on P2X3 receptors in KI TG neurons. (a) Representative traces of a,b-meATP
(10mM, 2 s)-evoked P2X3 responses in control and after application of o-agatoxin IVA (200 nM, 24 h) alone or in a combination with anantin
(500 ng/mL; coapplied during the last 3 h of o-agatoxin IVA treatment). Histograms on the right quantify current density values of P2X3
currents for each condition. Note that o-agatoxin IVA reduces P2X3 currents and that anantin can up-regulate them to the control level
(n¼ 23, 24, 25, *p< 0.05, Mann–Whitney rank sum test). (b) Western immunoblotting shows the amount of P2X3 pSer and total amount of
P2X3 receptors in control, after 24 h o-agatoxin IVA or o-agatoxin IVA plus anantin (500 nM, 3 h) treatment. b-tubulin III was used as loading
control. Histograms on the right show statistically higher P2X3 pSer value after o-agatoxin IVA application compared to control (n¼ 4;
*p< 0.05, Mann–Whitney rank sum test) with reversal by anantin application. (c) Top panel is a representative example of Western
immunoblotting showing the amount of P2X3 receptors in raft (R) and non-raft (NR) membrane fractions in control and after treatment with
o-agatoxin IVA (200 nM, 24h) or a combination of o-agatoxin IVA and anantin (500 ng/mL; 3 h). Flotillin bands indicate lipid raft membrane
fractions. Lower panel shows total amount of P2X3 receptors for each experimental condition; b-tubulin was used as loading control.
Histograms on the right quantify mean P2X3 values in lipid raft and non-raft membrane fractions (n¼ 4; *p< 0.05, Kruskal–Wallis test).
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responses when BNP was exogenously applied.
A multifarious role of endogenous BNP (depending on
its extracellular concentration) may, therefore, be exerted
on diﬀerent pain-sensing modalities mediated by P2X3 or
TRPV1 receptors. Experiments in vivo are necessary to
clarify this suggestion particularly in view of the report
that the plasma level of the BNP peptide precursor is
elevated in migraine patients.44
Figure 5. CGRP receptor antagonist CGRP 8-37 restores anantin effects on P2X3 receptors of KI TG neurons. (a) Representative traces of
P2X3 responses induced by application of a,b-meATP (10mM, 2 s) in control and after application of CGRP 8-37 (1mM, 24 h) alone or in a
combination with anantin (500 ng/mL; coapplied for the last 3 h of CGRP 8-37 treatment). Histograms on the right quantify current density
values of P2X3 currents for above mentioned conditions. Note that CGRP 8-37 reduces P2X3 currents and anantin can reverse them (n¼ 30,
33, 27, *p< 0.05, Mann–Whitney rank sum test). (b) Representative example of Western immunoblotting showing the amount of P2X3 pSer
and total amount of P2X3 receptors in control, after CGRP 8-37 (1mM, 24 h) or co-application of CGRP 8-37 and anantin (500 nM, 3 h).
b-tubulin was used as loading control. Histograms on the right show P2X3 pSer values for each experimental condition (n¼ 4). (c) Top panel
is a representative example of Western immunoblotting showing the amount of P2X3 receptors in raft (R) and non-raft (NR) membrane
fractions in control and after treatment with CGRP 8-37 (1mM, 24h) or a combination of CGRP 8-37 and anantin (500ng/mL; 3 h); flotillin
bands indicate lipid raft membrane fractions. Lower panel shows total amount of P2X3 receptors for each experimental condition; b-tubulin
was used as loading control. Histograms on the right quantify mean P2X3 values in lipid raft and non-raft membrane fractions (n¼ 3;
*p< 0.05, Kruskal–Wallis test). Note a reduction in the amount of P2X3 receptors in R and NR samples after CGRP 8-37 application. Anantin
relocates P2X3 receptors from non-raft to lipid raft membrane compartments when applied after CGRP 8-37 pretreatment.
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NPR-A-dependent downregulation of P2X3 receptors
is restored by reversing the KI phenotype
Next, we investigated what made P2X3 receptors of KI
neurons apparently disjointed from BNP/NPR-A consti-
tutive inhibition. Previous studies show that enhanced
P2X3 receptor activity in KI sensory neurons could be
normalized to the WT level upon prolong inactivation of
CaV2.1 channels with the selective inhibitor o-agatoxin
IVA.18,22 It is noteworthy that this toxin does not change
P2X3 receptors in WT neurons.18 When applied to KI
cultures, P2X3-mediated responses went back to the WT
level and were associated with raised pSer and membrane
redistribution of P2X3 receptors. Over this scenario of
reversed functional phenotype, application of anantin
could then potentiate P2X3 receptors (thereby unmask-
ing constitutive inhibition) and concomitantly decrease
their pSer level. Nevertheless, anantin did not change
P2X3 raft membrane distribution. This observation
was somewhat unexpected in view of the P2X3 receptor
redistribution that anantin causes in WT TG.23 These
data, thus, suggest that low pSer and lipid raft compart-
mentalization were individual actors in the complex pro-
cess of P2X3 upregulation, and that they are not
mutually exclusive.
Contrasting role of CGRP and BNP on P2X3 receptors
Increased release of endogenous CGRP in the KI TG is
an important mechanism regulating P2X3 membrane traf-
ﬁcking and function.15,16 Accordingly, the CGRP antag-
onist CGRP 8-37 reduces P2X3-mediated responses of KI
neurons without aﬀecting WT neurons28 (Figure 5). When
CGRP activity was blocked in KI TG, constitutive inhib-
ition by BNP/NPR-A could then be restored because ana-
ntin regained its delayed eﬀect on P2X3 lipid raft
membrane distribution and current magnitude. These
observations suggest that, in the dynamic equilibrium
between the opposite actions of CGRP and BNP on KI
P2X3 receptors, the eﬀect of CGRP was usually domin-
ant. The functionally opposite control by ambient CGRP
and BNP on P2X3 receptors did not include contrasting
regulation of P2X3 pSer level that was independent from
background CGRP concentration.
It should be noted that in KI TG in situ and in cul-
ture, there is a sterile neuroinﬂammatory environ-
ment35,45 with related increase in CGRP release from
neuronal and non-neuronal cells.16 Thus, the present
data suggest that there are multiple processes amplifying
the function of trigeminal P2X3 receptors in KI ganglia,
and that these mechanisms are potent enough to over-
come constitutive inhibition by BNP, at least in this gen-
etic model of migraine.
While the synthetic agonist a,b-meATP used in the pre-
sent study is selective for P2X3 homomeric receptors, it can
also activate heteromeric P2X2/3 receptors that mediate a
slowly desensitizing current component.46–48 Nonetheless,
colocalization of P2X2 and P2X3 subunits has been previ-
ously reported in a minority of mouse TG neurons.49
Furthermore, the contribution of the slow-desensitizing
P2X2-mediated component to the total a,b-meATP-induced
membrane current is relatively small and detectable in a few
trigeminal neurons only.26 This condition precluded a
systematic evaluation of BNP/NPR-A inhibition on hetero-
meric P2X2/3 receptors in trigeminal cultures.
Conclusions
Figure 6 summarizes our view on the dual regulation of
P2X3 receptors by BNP and CGRP. In WT cultures,
ambient CGRP is minimal and the NPR-A receptors,
Figure 6. Scheme of BNP/NPR-A-induced modulation of P2X3
receptors expressed on the membrane of WT and KI trigeminal
neurons. (a) In WT neurons, endogenous BNP acting through its
receptor NPR-A constitutively restrains P2X3 receptor activity.
This process is cGMP- and cGMP-dependent protein kinase-
dependent and involves high pSer (indicated by circled P) and
receptor redistribution from lipid rafts (red) to non-raft (white)
membrane compartments. Low activity of CaV2.1 channels and
virtually silent CGRP pathway do not generate enough P2X3
stimulation to overcome BNP-mediated inhibition. (b) In KI tri-
geminal neurons, elevated concentration of ambient CGRP and
gain-of-function of CaV2.1 extensively enhance P2X3 receptor
activity to the level when the inhibitory BNP/NPR-A pathway
becomes ineffective. This is associated with lower level of pSer and
receptor preferential redistribution to the lipid raft membrane
fraction. CGRP-R denotes the CGRP receptor complex.
GC¼ guanylyl cyclase.
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highly sensitive even to rather low BNP concentrations,
generate via cGMP and cGMP-dependent protein kinase
(PKG) activity an inhibitory control over P2X3 receptor
function. This condition is associated with two phenom-
ena: relatively high pSer and signiﬁcant presence of P2X3
receptors in non-raft compartments.
In KI neurons with enhanced Ca2þ inﬂux through
CaV2.1 channels, the NPR-A and P2X3 receptors
became functionally uncoupled for yet unknown reason,
as, despite intact cGMP responses to endogenous BNP,
the downstream signal could no longer impact the activity
of P2X3 receptors. It seems likely that the process of
P2X3 up-regulation underlying trigeminal sensitization
to pain19,43 might be triggered because excessive levels of
‘‘migraine mediators’’ like CGRP swamp the negative
BNP control that preserves a physiological pain thresh-
old. This notion accords with the observed stronger excit-
ability of KI TG neurons.17 While additional experiments
are required to clarify the exact molecular mechanisms
involved in this process, identifying strategies to enhance
intrinsic inhibition, even at peripheral level, may be useful
to control pain. In this sense, future in vivo experiments to
study any physiological relevance of the described modu-
lation will be necessary to further support the functional
impact of the current results.
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